P&S Intelligence

The spinal X-ray & CT market is set to grow at a 6.3% CAGR, reaching $1.6B by 2030, driven by AI advancements, rising spinal disorders, and expanding healthcare access.

The next-gen antibody market is set to reach $4.1B by 2030, driven by oncology dominance, ADC advancements, and rising R&D investments worldwide.

The cardiac biomarkers market is set to reach $44.6B by 2030, driven by rising heart disease cases, AI-driven diagnostics, and growing demand for point-of-care testing.

The U.S. biologics CDMO market is set to grow at an 11.7% CAGR, reaching $9.08B by 2032, driven by rising biologics demand, aging population, and tech advancements.

According to the latest market research study published by P&S Intelligence , the global patient temperature monitoring market to reach USD 4.1 billion in 2024.

The orthopedic biomaterials market is set to grow at a 7.3% CAGR, reaching $38.8B by 2032, driven by 3D printing, personalized implants, and advanced surgeries.

The digital biomarkers market is set to grow at a 29% CAGR, reaching $23.5B by 2032, driven by AI, mHealth, and rising demand for remote patient monitoring.

The U.S. embolotherapy market is set to grow at a 7.9% CAGR, reaching $2.69B by 2032, driven by rising chronic diseases, tech advancements, and minimal invasiveness.

The global X-ray imaging market will reach $10.9 billion by 2032, driven by digital advancements, rising chronic diseases, and growing demand for early diagnosis.

Asia-Pacific is leading the routing market surge, driven by rapid digital transformation, rising internet penetration, and IT infrastructure growth.